CD33 and Alzheimer disease: In particular, we found negative factors related to AD (including short sleep duration, CAD, schizophrenia, elevated LDL-C and CD33 protein levels, short telomeres, and high expression of CR1), which are crucial for setting inclusion and exclusion criteria in future population studies.